Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis
European Respiratory Journal · 2025-08 · 66 (2) · 2402400
DOI: 10.1183/13993003.02400-2024 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Respiratory Journal, online erschienen am 22.05.2025. Verfasst von Amber Meservey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Arterial Hypertension, Pulmonary Embolism, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Cardiovascular Medical Research and Education Fund, Division of Intramural Research.
Abstract (Originalsprache)
Background
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) cause right ventricular dysfunction with extrapulmonary sequelae including renal dysfunction. We sought to characterise renal dysfunction in PAH and CTEPH and to assess the effect of pulmonary hypertension treatment on renal function.
Methods
We performed an individual participant data meta-analysis of 6694 participants from 18 phase III randomised clinical trials of pulmonary hypertension therapies. We calculated estimated glomerular filtration rate (eGFR) using the race-agnostic 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
Results
The mean± sd age was 49.6±15.5 years, 78% were female and 58% had idiopathic PAH. A total of 907 (13.5%) participants had a baseline eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Université de Lorraine, Centre d'Investigations Cliniques Plurithématique 1433, INSERM DCAC, CHRU de Nancy, F-CRIN INI-CRCT, Vandoeuvre-lès-Nancy, France.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA jude.moutchiasuh@pennmedicine.upenn.edu.
ORCID-Profile: Amber Meservey, Guillaume Baudry, Steven M Kawut
Förderung
- NHLBI NIH HHS
- Cardiovascular Medical Research and Education Fund
- Division of Intramural Research
Zitieren
APA
Meservey, A., Al-Naamani, N., Minhas, J., Fritz, J. S., Appleby, D., Baudry, G., Girerd, N., Feng, R., Kawut, S. M., & Moutchia, J. (2025). Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis. European Respiratory Journal, 66(2), 2402400. https://doi.org/10.1183/13993003.02400-2024
Vancouver
Meservey A, Al-Naamani N, Minhas J, Fritz JS, Appleby D, Baudry G, et al. Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis. European Respiratory Journal. 2025;66(2):2402400. doi:10.1183/13993003.02400-2024
BibTeX
@article{Meservey2025,
author = {Meservey, Amber and Al-Naamani, Nadine and Minhas, Jasleen and Fritz, Jason S and Appleby, Dina and Baudry, Guillaume and Girerd, Nicolas and Feng, Rui and Kawut, Steven M and Moutchia, Jude},
title = {Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis},
journal = {European Respiratory Journal},
year = {2025},
volume = {66},
number = {2},
pages = {2402400},
doi = {10.1183/13993003.02400-2024}
}
EUVIMED